A Microfluidic Chip based Model for the Study of Full Thickness Human Intestinal Tissue

Video   Oct 18, 2016

 

The dual-flow device is designed to mimic the human body and maintain tissue in a functional state ex-vivo. This can be used for the investigation into diseases such as inflammatory bowel disease (IBD) including Crohns disease and Ulcerative Colitis. As the causes of IBD remain unknown many patients with extensive disease may develop complications that are potentially life-threatening, including an increased risk of colorectal cancer. The device has been characterised to ensure the tissue remains viable for up to 72 hours. Tissue has been investigated through measuring cell death via LDH release, cell proliferation via Ki-67 staining and MTS, and also through histology by H&E and PAS staining. IBD is thought to be caused by an influx of luminal content into the mucus layer of the gut stimulating an inflammatory response. Investigations using biopsies with an intact layer of mucus have shown that inflammatory markers (e.g. IL-10, IL-12 and calprotectin) are detectable in the effluent. The device provides a platform that allows the complex interaction between the host, mucus production and the commensal bacteria to be studied; providing a same species model for investigation of IBD. It is simple to use and is easily adopted by other research laboratories.

 
 
 
 

Recommended Videos

Droplet Microfluidics (A "Bad and Boujee" Rap Parody)

Video

Rap parody wins the MicroTAS Video Competition 2017.

WATCH NOW

Smoking Human Lung Small Airway on a Chip

Video

In this video, Wyss Founding Director Donald Ingber and Technology Development Fellow Kambez Benam explain how the integrated smoking device mimics normal cigarette smoke exposure and how it can impact research into the causes of COPD and into new biomarkers and therapeutics.

WATCH NOW

SPEDs: Self-powered, Paper-based Electrochemical Devices

Video

The self-powered, paper-based electrochemical devices, or SPEDs, are designed for sensitive diagnostics at the “point-of-care,” or when care is delivered to patients, in regions where the public has limited access to resources or sophisticated medical equipment.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE